FDA And FTC Join Forces On Biosimilars

Teaming Up To Eliminate Barriers To Biosimilar Competition

 
• By Brenda Sandburg
Conceptual business illustration with the words anti-competitive practices
FDA and FTC to target anticompetitive behavior that impedes access to biosimilars • Source: Shutterstock

More from Biosimilars

More from Products